Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Valmet’s co-determination negotiations for temporary lay-offs are completed

Valmet Oyj’s press release on December 2, 2020 at 9:30 a.m. EETValmet announced on November 24, 2020 the start of co-determination negotiations for temporary lay-offs in Finland. The negotiations were started due to financial and production related reasons, especially because of the reducing workload in the services business done close to customers. The global Covid-19 pandemic continues to cause uncertainty in Valmet’s operating environment. The negotiations concerned in total about 940 employees out of 1,680 employed by the Services business line and EMEA area organization in Finland.

Sectra and RSA Biomedical sign distribution agreement for Sectra’s CT-based method for clinical validation of orthopaedic implant stability

Linköping, Sweden – December 2, 2020 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has signed a distribution agreement with RSA Biomedical. Under the contract, RSA Biomedical will now offer Sectra CT-based Micromotion Analysis (Sectra CTMA®). This measurement method facilitates time and cost-efficient clinical validation of orthopaedic implant movement for the benefit of patient safety.“For the past two decades, we have supported orthopaedists and implant manufacturers by providing measurement methods for validating implants and our

New study shows Mangoral’s lesion visualization as effective as gadolinium contrast agent

Ascelia Pharma AB (publ) (ticker: ACE) today announced the results from an independent reader study where Mangoral was compared against a gadolinium-based liver specific contrast agent. The results showed that Mangoral was as effective as the gadolinium-based contrast agent gadobenate dimeglumine for visualization of focal liver lesions. The results also showed that Mangoral-enhanced MRI provides improved diagnostic efficacy compared to MRI without a contrast agent using identical endpoints as in Ascelia Pharma’s ongoing pivotal Phase 3 study SPARKLE.The blinded re-read study was performed

Riku Patokoski appointed new Business Unit President of Bonava Finland

Riku Patokoski has been appointed the new Business Unit President of Bonava Finland and member of Bonava’s Executive Management and will take office not later than 1 June 2021.–  We are very happy to welcome Riku Patokoski to Bonava. Riku has solid experience in construction and housing development, and his ability to manage complex operations will play a key role in efforts moving forward to supply high-quality housing units with stable profitability in the Finnish market, says Joachim Hallengren, President and CEO, Bonava.Riku Patokoski has extensive experience in the fields of

Dentalum acquires City Dental – one of Sweden’s largest private dental clinics

Dentalum Operations AB (publ) acquires City Dental in Stockholm, one of the largest private dental clinics in Sweden and the eleventh clinic to join the Dentalum group.City Dental is, as of 1 December 2020, the eleventh clinic to join Dentalum group. City Dental, located on Drottninggatan in the city center of Stockholm, is with its 17 treatment rooms one of Sweden's single largest private dental clinic. The clinic was founded over 15 years ago by Mattias Santesson with the ambition to provide accessible and high-quality dental care at an affordable price. Today, City Dental offers full

GenesisCare selects Dignitana as preferred scalp cooling provider for its rapidly expanding Australia medical oncology centres

Dignitana  has been selected as the preferred scalp cooling provider by Australia-headquartered GenesisCare , one of the largest networks of integrated oncology care in the world. This is Dignitana’s largest single commitment for DigniCap Delta units since the next generation device launched in 2019. The DigniCap[®] Scalp Cooling System minimizes hair loss from chemotherapy in patients with solid tumors.The partnership will see the roll out of DigniCap Delta systems across GenesisCare’s seven pre-existing medical oncology facilities

Kojamo to host Investors’ Day today on 2 December 2020 at 2:00 p.m. EET

Kojamo Plc Press Release, 2 December 2020 at 9:00 a.m. EETKojamo to host Investors’ Day today on 2 December 2020 at 2:00 p.m. EET Kojamo hosts its first Investors’ Day today on 2 December 2020 from 2:00 p.m. to 4:10 p.m. EET. The event is virtual. The purpose of the day is to increase understanding on Kojamo as an investment. The topics of the event are Kojamo’s digital roadmap, sustainability programme to be published today and development projects. These themes are strongly related to Kojamo’s strategic focal points. The speakers of the event will be Jani Nieminen, Chief Executive

Electrolux Professional launches sustainability commitments

Electrolux Professional today announces its Sustainability commitments. We are supporting a sustainable business based on the United Nations Sustainability Development Goals and the Paris agreement. The ambition is to become climate neutral from operations by 2030.Electrolux Professional´s mission is to make customers' work-life easier, more profitable - and truly sustainable - every day. This means striving to improve sustainability in customers value chain while focusing on reducing impacts within our own business, keeping stakeholders in mind and acting responsibly. We want to earn trust

Peab rebuilds highway 23 outside of Växjö

Peab has been commissioned to rebuild ten kilometers of highway 23 between Huseby and Marklanda which is on the stretch between Älmhult and Växjö. The road section will become a divided highway with a center guardrail. The customer is the Swedish Transport Administration and the contract is worth SEK 159 million.The road section will be rebuilt to improve traffic safety and passability. It will be broadened from eight meters to 13 meters and rebuilt into a divided 2+1 highway with a center guardrail. “Naturally we are pleased to contribute to improving traffic safety and passability on

Elkem opens new workshop in China dedicated to specialised silicones for hybrid and electric vehicles

Elkem has completed and opened a new production workshop in Shanghai, China, dedicated to the development and manufacturing of specialised silicones for hybrid and electric vehicles. This move further strengthens Elkem’s position as the largest silicones producer in China.China is the world’s largest single market for the production and sales of electric vehicles (EV). The global demand for EV’s is growing fast, and some analysts now expect EV’s to account for around a third of new car sales by 2030. Increased sales of hybrids and EV’s represent a substantial growth opportunity for Elkem,

Olvi Plc’s Financial Reports in 2021

Olvi Plc                Stock Exchange Release 2 Dec 2020 at 9.00 am Olvi Plc’s Financial Reports in 2021 Olvi plc will issue a bulletin on the 2020 financial statements on 23 February 2021. The annual report will be released during week 11. The annual report will include the Board of Directors’ report, the Group’s and the parent company’s financial statements, as well as the auditors’ report regarding the accounting period 1 January to 31 December 2020. The annual report includes corporate responsibility report. At the same time, the company will issue its corporate governance

Hexagon Purus AS: Contemplated private placement and admission to trading on Euronext Growth Oslo

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Hexagon Purus AS (the “Company” or “Hexagon Purus” or “Purus”) has engaged Carnegie AS and Skandinaviska Enskilda Banken AB (publ) as Joint Bookrunners (together the “Managers”) to advise on and effect a contemplated private placement of new shares

UPM has completed employee consultation processes

(UPM, Helsinki, 2 December 2020 at 09:00 EET) – UPM has completed the employee consultation process started in October on its plans to improve efficiency in global functions. UPM increases efficiency of its global functions by reorganising and streamlining the functions’ operations in five countries. This will decrease the number of positions in the functions by 67, of which 46 in Finland. UPM has also concluded the consultations regarding the reorganisation and restructuring at the Finnish pulp mills and UPM Forest that were announced in August. The consultations led to a reduction of

Skanska builds care facilities in California, USA, for USD 90 M, about SEK 770 M

Skanska has signed a contract with San Mateo County to build five new buildings for Cordilleras Health System in Redwood City, California. The contract is worth USD 90 M, about SEK 770 M, which will be included in the US order bookings for the fourth quarter of 2020.The project includes four new Mental Health Rehabilitations Centers (MHRC) containing 16 beds for long-term mental healthcare. Additionally, there will be a new three-story, co-housing building that will support transitional clients. Construction began in November 2020 and is scheduled for completion in December 2023.

Scandinavian Biogas intends to carry out a private placement and listing of its dark green shares on Nasdaq First North Premier Growth Market

THIS PRESS RELEASE IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES IN ACCORDANCE WITH APPLICABLE LAW. PLEASE REFER TO "IMPORTANT INFORMATION" AT THE END OF THE PRESS RELEASE.Scandinavian Biogas Fuels International AB (publ) (“Scandinavian Biogas” or the “Company”), a

Storytel goes live in Thailand today

Storytel, one of the world’s leading audiobook and e-book streaming services, went live today in Thailand. The launch strengthens Storytel’s presence in the Asia Pacific region, where the company since previously has operations in India, Singapore and South Korea.Storytel has an audiobook production unit running in Thailand since 2019. By launching the app Storytel now opens up for audiobooks and e-books in Thai for a population of almost 70 million people.  “With our launch in Thailand we continue to expand our presence in APAC, strengthening our position as the number one ‘glocal’

Clas Ohlson six-month report 2020/21

Improved result in an uncertain world Second quarter – 1 August to 31 October 2020 • Sales declined 6% to 2,036 MSEK (2,165), organic growth down 1% and down 1% in comparable units • Online sales increased by 25% to 148 MSEK (119) • Operating profit totalled 148 MSEK (133). Excluding the effect of IFRS 16, operating profit totalled 130 MSEK (107). • The operating margin was 7.3% (6.1). Excluding the effect of IFRS 16, the operating margin was 6.4% (4.9). • Net debt/EBITDA excluding the effect of IFRS 16 (12 months) amounted to -0.3 times (0.6) • Profit after tax totalled

Camurus announces that Braeburn receives Complete Response Letter for Brixadi for opioid use disorder in the US

Lund, Sweden — 2 December 2020 — Camurus AB (NASDAQ STO: CAMX) today announced that Camurus licensee Braeburn has received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) regarding its new drug application (NDA) for Brixadi™ (buprenorphine) extended-release weekly and monthly injections for the treatment of moderate to severe opioid use disorder. The CRL follows a recent pre-approval inspection of Braeburn’s third-party manufacturer of Brixadi in the US, during which quality related deficiencies were identified. According to Braeburn, they are committed to

NOTICE OF EXTRA GENERAL MEETING IN ENAD GLOBAL 7 AB (PUBL)

The shareholders of Enad Global 7 AB (publ), reg. no. 556923-2837, (the "Company") are hereby invited to the extra general meeting on Thursday 17 December 2020 at 10.00 a.m. CET at Baker & McKenzie's premises at Vasagatan 7 in Stockholm. Information with respect to the coronavirus Due to the development of the coronavirus the goal is that the general meeting shall be swift and effective to minimize spread of disease. Shareholders should carefully consider the possibility to vote in advance, please see below, as well as the possibility of participating by way of proxy. Shareholders who

Swedish Stirling completes a directed issue of 5 million shares, raising proceeds of SEK 67.5 million

The Board of Directors of Swedish Stirling AB (publ) (“Swedish Stirling” or the “Company”) has resolved to carry out a directed issue of 5,000,000 new shares (the “Directed Issue”). The Directed Issue generated a large interest and investors were new Swedish and institutional investors, among others, BNP Paribas Energy Transition and Daniel Ek (indirectly through company), as well as certain existing shareholders. The subscription price was determined based on an accelerated book building procedure and set at SEK 13.50 per share. Swedish Stirling will raise proceeds amounting to SEK 67,500,

Asetek A/S Announces Transactions Carried Out Under the Current Share Buyback Programme in Accordance With the "Safe Harbour Method"

December 1, 2020 - On October 23, 2020, Asetek A/S launched a share buyback programme, as described in company announcement of October 23, 2020. According to the programme, Asetek A/S will in the period until March 5, 2021 buy back own shares up to a maximum value of USD 4 million and with a maximum of 381,000 shares. The share buyback programme will be implemented in accordance with Regulation (EU) no. 596/2014 of 16th April 2014 of the European Parliament and Council and  ommission Delegated Regulation (EU) no. 2016/1052, also referred to as the Safe Harbour rules. Trading day

Targovax announces impressive objective responses as well as effects on non-injected lesions in ONCOS-102 trial in anti-PD1 refractory melanoma patients

· Tumor responses observed in 7 out of 20 evaluable patients, resulting in best objective response rate (ORR) of 35% · Systemic effects observed in multiple patients, including two examples where a non-injected lesion completely regressed · An online presentation by Targovax’s management will take place at 10:00 CET 2 December 2020 (details below)Oslo, Norway, 1 December 2020 - Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, today announces that the combination of ONCOS-102 and pembrolizumab (

There are no items matching the current filter
There are no more items matching the current filter
Back to top